Assessment of Central Corneal Thickness in Different Subtypes of Systemic Sclerosis

REFERENCES

• Ehlers N, Hjortdal J. Corneal thickness: measurement and implications. Exp Eye Res. 2004;78(3):543–548.
   PubMed Web of Science ®Google Scholar
• Santhiago M, Smadja D, Gomes B, et al. Association between the percent tissue altered and post-laser in situ keratomileusis ectasia in eyes with normal preoperative topography. Am J Ophthalmol. 2014;158(1):87–95.
   PubMed Web of Science ®Google Scholar
• Lee J, Oum B, Choi H, et al. Differences in corneal thickness and corneal endothelium related to duration in diabetes. Eye (Lond). 2006;20(3):315–318.
   PubMed Web of Science ®Google Scholar
• Ozdamar Y, Berker N, Ertugrul G, et al. Is there a change of corneal thickness in uveitis with Behçet disease? Cornea. 2010;29(11):1265–1267.
   PubMed Web of Science ®Google Scholar
• Razeghinejad M, Safavian H. Central corneal thickness in patients with Weill-Marchesani syndrome. Am J Ophthalmol. 2006;142(3):507–508.
   PubMed Web of Science ®Google Scholar
• Cumurcu T, Cumurcu B, Kilic R, et al. Increased central corneal thickness in children with cerebral palsy. Cornea. 2009(28):375–378.
   Google Scholar
• Akinci A, Bulus D, Aycan Z, et al. Central corneal thickness in children with diabetes. J Refract Surg. 2009;25(11): 1041–1044.
   PubMed Web of Science ®Google Scholar
• Villani E, Galimberti D, Viola F, et al. Corneal involvement in rheumatoid arthritis: an in vivo confocal study. Invest Ophthalmol Vis Sci. 2008;49(2):560–564.
   PubMed Web of Science ®Google Scholar
• Villani E, Galimberti D, Viola F, et al. The cornea in Sjögren’s syndrome: an in vivo confocal study. Invest Ophthalmol Vis Sci. 2007;48(5):2017–2022.
   PubMed Web of Science ®Google Scholar
• Ortak H, Inanır A, Demir S, et al. Decreased central corneal thickness in ankylosing spondylitis. Int Ophthalmol. 2014;34(2): 263–268.
   PubMed Web of Science ®Google Scholar
• Brandt J. Corneal thickness in glaucoma screening, diagnosis, and management. Curr Opin Ophthalmol. 2004;15(2):85–89.
   PubMedGoogle Scholar
• Derk C, Jimenez S. Systemic sclerosis: current views of its pathogenesis. Autoimmun Rev. 2003;2(4):181–191.
   PubMed Web of Science ®Google Scholar
• Serup L, Serup J, Hagdrup H. Increased central cornea thickness in systemic sclerosis. Acta Ophthalmol (Copenh). 1984;62(1):69–74.
   PubMed Web of Science ®Google Scholar
• Emre S, Kayikçioğlu O, Ateş H, et al. Corneal hysteresis, corneal resistance factor, and intraocular pressure measurement in patients with scleroderma using the Reichert ocular response analyzer. Cornea. 2010;29(6):628–631.
   PubMed Web of Science ®Google Scholar
• Gomes BA, Santhiago M, Kara-Junior N, et al. Central corneal thickness in patients with systemic sclerosis: a controlled study. Cornea. 2011;30(10):1125–1128.
   PubMed Web of Science ®Google Scholar
• Valentini G, Della Rossa A, Bombardieri S, et al. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis. 2001;60(6):592–598.
   PubMed Web of Science ®Google Scholar
• LeRoy E, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202–205.
   PubMed Web of Science ®Google Scholar
• Simeón-Aznar C, Fonollosa-Plá V, Tolosa-Vilella C, et al. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status. Semin Arthritis Rheum. 2012;41(6): 789–800.
   PubMed Web of Science ®Google Scholar
• Walker U, Tyndall A, Czirják L, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis. 2007;66(6):754–763.
   PubMed Web of Science ®Google Scholar
• Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581–590.
   PubMed Web of Science ®Google Scholar
• Behrens A, Doyle J, Stern L, et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea. 2006;25(8):900–907.
   PubMed Web of Science ®Google Scholar
• Kuhn A, Haust M, Ruland V, et al. Effect of bosentan on skin fibrosis in patients with systemic sclerosis: a prospective, open-label, non-comparative trial. Rheumatology (Oxford). 2010;49(7):1336–1345.
   PubMed Web of Science ®Google Scholar
• Giordano N, Puccetti L, Papakostas P, et al. Bosentan treatment for Raynaud’s phenomenon and skin fibrosis in patients with systemic sclerosis and pulmonary arterial hypertension: an open-label, observational, retrospective study. Int J Immunopathol Pharmacol. 2010;23(4):1185–1194.
   PubMed Web of Science ®Google Scholar
• Hachulla E, Launay D. Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol. 2011;40(2):78–83.
   PubMed Web of Science ®Google Scholar
• Krieg T, Takehara K. Skin disease: a cardinal feature of systemic sclerosis. Rheumatology (Oxford). 2009;48(Suppl 3):iii14–iii18.
   PubMedGoogle Scholar
• Gabrielli A, Avvedimento E, Krieg T. Scleroderma. N Engl J Med. 2009;360( 19):1989–2003.
   Google Scholar
• Galluccio F, Walker U, Nihtyanova S, et al. Registries in systemic sclerosis: a worldwide experience. Rheumatology (Oxford). 2011;50(1):60–68.
   PubMed Web of Science ®Google Scholar
• Gonzalez R, Storr M, Bloching H, et al. Autoantibody profile in progressive systemic sclerosis as markers for esophageal involvement. J Clin Gastroenterol. 2001;32(2):123–127.
   PubMed Web of Science ®Google Scholar
• Doughty M, Zaman M. Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach. Surv Ophthalmol. 2000;44(5):367–408.
   PubMed Web of Science ®Google Scholar
• Chua J, Tham Y, Liao J, et al. Ethnic differences of intraocular pressure and central corneal thickness: the Singapore Epidemiology of Eye Diseases Study. Ophthalmology. 2014;121(10):2013–2022.
   PubMed Web of Science ®Google Scholar
• Shimmyo M, Ross A, Moy A, et al. Intraocular pressure, Goldmann applanation tension, corneal thickness, and corneal curvature in Caucasians, Asians, Hispanics, and African Americans. Am J Ophthalmol. 2003;136(4):603–613.
   PubMed Web of Science ®Google Scholar
• Boquett J, Schüler-Faccini L, Jobim L, et al. Self-assessment of color categories and its relationship with hla profiling in Brazilian bone marrow donors. Biol Blood Marrow Transplant. 2015;21(6):1140–1144.
   PubMedGoogle Scholar
• Ferri C, Sebastiani M, Lo Monaco A, et al. Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients’ population and review of the literature. Autoimmun Rev. 2014;13(10):1026–1034.
   PubMed Web of Science ®Google Scholar
• Bournia V, Vlachoyiannopoulos P, Selmi C, et al. Recent advances in the treatment of systemic sclerosis. Clinic Rev Allerg Immunol. 2009;36(2–3):176–200.
   PubMed Web of Science ®Google Scholar
• Sampaio-Barros P, Zimmermann A, Müller CS, et al. Recommendations for the management and treatment of systemic sclerosis. Rev Bras Reumatol. 2013;53(3):258–275.
   PubMed Web of Science ®Google Scholar
• Topal A, Dhurat R. Scleroderma therapy: clinical overview of current trends and future perspective. Rheumatol Int. 2013;33(1):1–18.
   PubMed Web of Science ®Google Scholar
• Kaloudi O, Bandinelli F, Filippucci E, et al. High frequency ultrasound measurement of digital dermal thickness in systemic sclerosis. Ann Rheum Dis. 2010;69(6):1140–1143.
   PubMed Web of Science ®Google Scholar
• Medsger TJ. Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin North Am. 2003;29(2):255–273.
   PubMed Web of Science ®Google Scholar
• Gomes BA, Santhiago M, Magalhães P, et al. Ocular findings in patients with systemic sclerosis. Clinics (Sao Paulo). 2011;66(3):379–385.
   PubMed Web of Science ®Google Scholar
• Waszczykowska A, Goś R, Waszczykowska E, et al. Prevalence of ocular manifestations in systemic sclerosis patients. Arch Med Sci. 2013;9(6):1107–1113.
   PubMed Web of Science ®Google Scholar
• Tailor R, Gupta A, Herrick A, et al. Ocular manifestations of scleroderma. Surv Ophthalmol. 2009;54(2):292–304.
   PubMed Web of Science ®Google Scholar